Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome

American Journal of the Medical Sciences

Volumn 343, Issue 6, 2012, Pages 446-451

  Seeds, Michael C ^a   Grier, Bonnie L ^a   Suckling, Bruce N ^a   Safta, Anca M ^a   Long, David L ^a   Waite, B Moseley ^a   Morris, Peter E ^a   Hite, R Duncan ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Adult respiratory distress syndrome; Phosphatidylglycerol; Pulmonary surfactant; Secretory phospholipase A2

Indexed keywords

LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE A2;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; LUNG ALVEOLUS SURFACE TENSION; LUNG FLUID; LUNG LAVAGE;

EID: 84862882764     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318239c96c     Document Type: Article

References (50)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24. (Pubitemid 24082248)
2. Zuo YY, Veldhuizen RA, Neumann AW, et al. Current perspectives in pulmonary surfactant-inhibition, enhancement and evaluation. Biochim Biophys Acta 2008;1778:1947-77.
3. Kim DK, Fukuda T, Thompson BT, et al. Bronchoalveolar lavage fluid phospholipase A2 activities are increased in human adult respira tory distress syndrome. Am J Physiol Lung Cell Mol Physiol 1995;269:L109-18.
4. Holm BA, Keicher L, Liu MY, et al. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991;71:317-21.
5. Arbibe L, Koumanov K, Vial D, et al. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998;102:1152-60. (Pubitemid 28436275)
6. Lambeau G, Gelb MH. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 2008;77:495-520.
7. Touqui L, Wu YZ. Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome. Acta Pharmacol Sin 2003;24:1292-6. (Pubitemid 37509440)
8. Aarsman AJ, Neys FW, van der Helm HA, et al. Sera of patients suffering from inflammatory diseases contain group IIA but not group V phospholipase A(2). Biochim Biophys Acta 2000;1502:257-63.
9. Seeds MC, Jones KA, Duncan HR, et al. Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells. Am J Respir Cell Mol Biol 2000;23:37-44. (Pubitemid 30597093)
10. Granata F, Nardicchi V, Loffredo S, et al. Secreted phospholipases A (2): a proinflammatory connection between macrophages and mast cells in the human lung. Immunobiology 2009;214:811-21.
11. Nevalainen TJ, Eerola LI, Rintala E, et al. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta 2005;1733:210-23. (Pubitemid 40603664)
12. Nakos G, Kitsiouli E, Hatzidald E, et al. Phospholipases A2 and platelet-Activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005;33:772-9.
13. Touqui L, Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999;5:244-9.
14. Neidlinger NA, Hirvela ER, Skinner RA, et al. Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg 2005;200:173-8. (Pubitemid 40143206)
15. Hite RD, Seeds MC, Jacinto RB, et al. Hydrolysis of surfactantassociated phosphatidylcholine by mammalian secretory phospholipases A2. Am J Physiol 1998;275:L740-7.
16. Hite RD, Seeds MC, Safta AM, et al. Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated sur factantdysfunction. Am J Physiol Lung Cell Mol Physiol 2005;288: L618-24. (Pubitemid 40404128)
17. Attalah HL, Wu Y, Alaoui-El-Azher M, et al. Induction of type-II A secretory phospholipase A2 in animal models of acute lung injury. Eur Respir J 2003;21:1040-5. (Pubitemid 36675623)
18. Hite RD, Seeds MC, Bowton DL, et al. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol 2005;288:L610-7. (Pubitemid 40404127)
19. Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 2009; 1792:941-53.
20. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993;74:2922-7. (Pubitemid 23201325)
21. Nag K, Munro JG, Inchley K, et al. SP-B refining of pulmonary surfactant phospholipid films. Am J Physiol 1999;277:L1179-89. (Pubitemid 30046046)
22. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81.
23. Gunther A, Ruppert C, Schmidt R, et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001; 2: 353-64. (Pubitemid 34189664)
24. Rouser G, Fkeischer S, Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970;5:494-6.
25. Singer AG, Ghomashchi F, Le Calvez C, et al. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 2002;277: 48535-49. (Pubitemid 35470814)
26. Jarjour NN, Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999;160:336-41. (Pubitemid 29326109)
27. Seeger W, Pison U, Buchhorn R, et al. Surfactant abnormalities and adult respiratory failure. Lung 1990;168(suppl):891-902. (Pubitemid 20217744)
28. Schmidt R, Markart P, Ruppert C, et al. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 2007;8: 55.e1-11.
29. Beck S, Lambeau G, Scholz-Pedretti K, et al. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-Activated receptor alpha activation. J Biol Chem 2003;278:29799-812. (Pubitemid 36962367)
30. Crowl RM, Stoller TJ, Conroy RR, et al. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991;266:2647-51. (Pubitemid 21909111)
31. Seeds MC, Jones DF, Chilton FH, et al. Secretory and cytosolic phospholipases A2 are activated during TNF priming of human neutrophils. Biochim Biophys Acta 1998;1389:273-84. (Pubitemid 28097323)
32. Park WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1896-903. (Pubitemid 33152327)
33. Lee YL, Chen W, Chen LY, et al. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe communityacquired pneumonia. J Crit Care 2010;25:176.e7-13.
34. Hallstrand TS, Chi EY, Singer AG, et al. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007;176:1072-8. (Pubitemid 350223752)
35. Munoz NM, Meliton AY, Meliton LN, et al. Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 2009;296: L879-87.
36. Wootton PT, Drenos F, Cooper JA, et al. Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. Hum Mol Genet 2006;15:355-61. (Pubitemid 43125989)
37. Touqui L, Paya M, Thouron F, et al. Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages. FEBS Lett 2005;579:4923-7. (Pubitemid 41242832)
38. Kuronuma K, Mitsuzawa H, Takeda K, et al. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 2009;284:25488-500.
39. Kimura-Matsumoto M, Ishikawa Y, Komiyama K, et al. Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis 2008;196:81-91.
40. Degousee N, Ghomashchi F, Stefanski E, et al. Groups IV, V and X phospholipases A2 in human neutrophils. Role in eicosanoid production and gram negative bacterial phospholipid hydrolysis. J Biol Chem 2001; 277:5061-73. (Pubitemid 34968547)
41. Yu SH, Possmayer F. Lipid compositional analysis of pulmonary surfactant monolayers and monolayer-Associated reservoirs. J Lipid Res 2003;44:621-9. (Pubitemid 37279712)
42. Numata M, Chu HW, Dakhama A, et al. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci USA 2010;107:320-5.
43. Spyridkis S, Leondaritis G, Nakos G, et al. A specific phospholipase C activity regulates phosphatidylinositol levels in lung surfactant of ARDS patients. Am J Respir Cell Mol Biol 2010;42:357-62.
44. Postle AD, Heeley EL, Wilton DC. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol 2001;129:65-73. (Pubitemid 32455707)
45. Hite RD, Seeds MC, Jacinto RB, et al. Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis. Biochim Biophys Acta 2005;1720: 14-21. (Pubitemid 43202130)
46. Poelma DL, Ju MR, Bakker SC, et al. A common pathway for the uptake of surfactant lipids by alveolar cells. Am J Respir Cell Mol Biol 2004;30:751-8. (Pubitemid 38591228)
47. Gunther A, Schmidt R, Feustel A, et al. Surfactant subtype conver sion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies. Am J Respir Crit Care Med 1999;159:244-51. (Pubitemid 29036530)
48. Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-92.
49. Wiswell TE, Smith RM, Katz LB, et al. Bronchopulmonary segmental lavage with surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;160:1188-95. (Pubitemid 29487458)
50. Merrill JD, Ballard RA. Pulmonary surfactant for neonatal respiratory disorders. Curr Opin Pediatr 2003;15:149-54. (Pubitemid 36337824)